These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 26347939)
21. A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours. García-Garayoa E; Bläuenstein P; Blanc A; Maes V; Tourwé D; Schubiger PA Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):37-47. PubMed ID: 18690434 [TBL] [Abstract][Full Text] [Related]
22. Design of Radiolabeled Analogs of Minigastrin by Multiple Amide-to-Triazole Substitutions. Grob NM; Schmid S; Schibli R; Behe M; Mindt TL J Med Chem; 2020 May; 63(9):4496-4505. PubMed ID: 32302130 [TBL] [Abstract][Full Text] [Related]
23. Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs. Bergmann R; Scheunemann M; Heichert C; Mäding P; Wittrisch H; Kretzschmar M; Rodig H; Tourwé D; Iterbeke K; Chavatte K; Zips D; Reubi JC; Johannsen B Nucl Med Biol; 2002 Jan; 29(1):61-72. PubMed ID: 11786277 [TBL] [Abstract][Full Text] [Related]
24. Stabilization of the cysteine-rich conotoxin MrIA by using a 1,2,3-triazole as a disulfide bond mimetic. Gori A; Wang CI; Harvey PJ; Rosengren KJ; Bhola RF; Gelmi ML; Longhi R; Christie MJ; Lewis RJ; Alewood PF; Brust A Angew Chem Int Ed Engl; 2015 Jan; 54(4):1361-4. PubMed ID: 25483297 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of novel multimeric neurotensin(8-13) analogs. Hultsch C; Pawelke B; Bergmann R; Wuest F Bioorg Med Chem; 2006 Sep; 14(17):5913-20. PubMed ID: 16735124 [TBL] [Abstract][Full Text] [Related]
26. Peptide backbone modifications on the C-terminal hexapeptide of neurotensin. Einsiedel J; Hübner H; Hervet M; Härterich S; Koschatzky S; Gmeiner P Bioorg Med Chem Lett; 2008 Mar; 18(6):2013-8. PubMed ID: 18276136 [TBL] [Abstract][Full Text] [Related]
27. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues. Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066 [TBL] [Abstract][Full Text] [Related]
28. Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents. Falciani C; Brunetti J; Pagliuca C; Menichetti S; Vitellozzi L; Lelli B; Pini A; Bracci L ChemMedChem; 2010 Apr; 5(4):567-74. PubMed ID: 20222099 [TBL] [Abstract][Full Text] [Related]
29. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids. Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797 [TBL] [Abstract][Full Text] [Related]
30. Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues. Sefler AM; He JX; Sawyer TK; Holub KE; Omecinsky DO; Reily MD; Thanabal V; Akunne HC; Cody WL J Med Chem; 1995 Jan; 38(2):249-57. PubMed ID: 7830267 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities. Lundquist JT; Büllesbach EE; Dix TA Bioorg Med Chem Lett; 2000 Mar; 10(5):453-5. PubMed ID: 10743946 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues. Fanelli R; Besserer-Offroy É; René A; Côté J; Tétreault P; Collerette-Tremblay J; Longpré JM; Leduc R; Martinez J; Sarret P; Cavelier F J Med Chem; 2015 Oct; 58(19):7785-95. PubMed ID: 26348111 [TBL] [Abstract][Full Text] [Related]
33. Enantioselective syntheses of alpha-Fmoc-Pbf-[2-(13)C]-L-arginine and Fmoc-[1,3-(13)C2]-L-proline and Incorporation into the neurotensin receptor 1 ligand, NT(8-13). Song C; Tapaneeyakorn S; Murphy AC; Butts C; Watts A; Willis CL J Org Chem; 2009 Dec; 74(23):8980-7. PubMed ID: 19883062 [TBL] [Abstract][Full Text] [Related]
34. Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides. Falciani C; Accardo A; Brunetti J; Tesauro D; Lelli B; Pini A; Bracci L; Morelli G ChemMedChem; 2011 Apr; 6(4):678-85. PubMed ID: 21370475 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and fluorescence property evaluation of blue emitting triazole-linked chromene peptidomimetics. Mohan TJ; Bahulayan D Mol Divers; 2017 Aug; 21(3):585-596. PubMed ID: 28477103 [TBL] [Abstract][Full Text] [Related]
36. Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples. Keller M; Kuhn KK; Einsiedel J; Hübner H; Biselli S; Mollereau C; Wifling D; Svobodová J; Bernhardt G; Cabrele C; Vanderheyden PM; Gmeiner P; Buschauer A J Med Chem; 2016 Mar; 59(5):1925-45. PubMed ID: 26824643 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine. Lundquist JT; Dix TA J Med Chem; 1999 Nov; 42(23):4914-8. PubMed ID: 10579853 [TBL] [Abstract][Full Text] [Related]
38. Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding. Bruehlmeier M; Garayoa EG; Blanc A; Holzer B; Gergely S; Tourwé D; Schubiger PA; Bläuenstein P Nucl Med Biol; 2002 Apr; 29(3):321-7. PubMed ID: 11929702 [TBL] [Abstract][Full Text] [Related]
39. 1,2,3-Triazoles as amide bond mimics: triazole scan yields protease-resistant peptidomimetics for tumor targeting. Valverde IE; Bauman A; Kluba CA; Vomstein S; Walter MA; Mindt TL Angew Chem Int Ed Engl; 2013 Aug; 52(34):8957-60. PubMed ID: 23832715 [No Abstract] [Full Text] [Related]
40. Investigation of the Biological Impact of Charge Distribution on a NTR1-Targeted Peptide. Jia Y; Zhang W; Fan W; Brusnahan S; Garrison J Bioconjug Chem; 2016 Nov; 27(11):2658-2668. PubMed ID: 27661393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]